Max Healthcare Institute Limited

NSE:MAXHEALTH.NS

1079.25 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q1
Omzet 17,074.615,429.514,22913,349.713,631.612,849.912,179.711,412.411,371.210,662.78,905.39,741.610,183.310,001.77,7967,9566,509.42,562.710,505.42,6712,805.57,1901,969.351,969.356,6406,4106,660
Kosten van de omzet 10,717.110,011.89,003.12,672.82,797.92,758.5460.72,298.32,263.32,197.81,998.22,094.42,532.62,603.81,759.71,9151,617.5651.92,290.1539.3547.15,000350.55350.554,5204,6404,500
Brutowinst 6,357.55,417.75,225.910,676.910,833.710,091.411,7199,114.19,107.98,464.96,907.17,647.27,650.77,397.96,036.36,0414,891.91,910.88,215.32,131.72,258.42,1901,618.81,618.82,1201,7702,160
Brutowinstmarge 0.3720.3510.3670.80.7950.7850.9620.7990.8010.7940.7760.7850.7510.740.7740.7590.7520.7460.7820.7980.8050.3050.8220.8220.3190.2760.324
Onderzoek- en ontwikkelingskosten 0000003.600000000000000000000
Algemene en administratieve kosten 03,275.32,925.52,760.62,772.52,710.32,6202,425.52,4452,372.63,1762,112.12,025.51,768.32,176.51,679.51,392.6583.93,077.9601.2639.4310350350340340360
Verkoop- en marketingkosten 0-962.7-811.7000575.5000446.2000167.5000254.5001,130108.55108.551,1301,1401,160
Verkoop-, algemene en administratieve kosten 2,693.62,312.62,113.82,760.62,772.52,710.32,6202,425.52,4452,372.63,622.22,112.12,025.51,768.32,3441,679.51,392.6583.93,332.4601.2639.41,4401,085.41,085.41,4701,4801,520
Overige kosten 037.370.654.241.552.4-756.2451.5258.2315.1-336.6288.7114.275.6-765395.2403.211.5-125.3105.839.2000000
Bedrijfskosten 2,693.62,312.62,113.87,427.97,5397,275.86,884.56,549.96,495.56,392.64,848.75,741.35,798.95,491.84,285.34,923.94,588.42,4176,827.32,022.22,091.91,8002,134.852,134.851,8501,8501,850
Bedrijfsresultaat 3,663.93,105.13,112.13,709.23,749.52,815.63,202.13,015.72,870.62,072.31,883.51,905.91,851.82,3921,847.51,117.1706.71,512.31,751.8215.3205.7390194.55194.55270-90310
Bedrijfsresultaat ratio 0.2150.2010.2190.2780.2750.2190.2630.2640.2520.1940.2120.1960.1820.2390.2370.140.1090.590.1670.0810.0730.0540.0990.0990.041-0.0140.047
Totaal overige inkomsten en kosten netto 73108245.2-112.4-85.3219.3-195.3-201.3-218.491.5-339.6224.5-35.6-261.6-802.8-68.2-532.4-463.4-890.9-271.7-208.8-35057.0557.05-330-270-320
Inkomen voor belasting 3,736.93,213.13,357.33,596.83,664.23,034.93,006.82,814.42,652.22,163.81,543.92,130.41,816.21,898.51,044.71,048.9174.3-3,001.7860.9-56.4-3.140251.6251.6-60-360-10
Inkomen voor belasting ratio 0.2190.2080.2360.2690.2690.2360.2470.2470.2330.2030.1730.2190.1780.190.1340.1320.027-1.1710.082-0.021-0.0010.0060.1280.128-0.009-0.056-0.002
Belastingkosten 918.8850.4841.9703.4897.4634.1497.6590.3-1,921.3435.5306.6232.9369.7429.3347.8145.343.2-89.7-61.3-0.2-0.52027.5527.55101020
Nettowinst 2,818.12,362.72,515.42,893.42,766.82,400.82,509.22,224.14,573.51,728.31,237.31,897.51,446.51,469.2696.9903.6131.1-3,142.5895-18-13.620209.95209.95-70-370-30
Nettowinstmarge 0.1650.1530.1770.2170.2030.1870.2060.1950.4020.1620.1390.1950.1420.1470.0890.1140.02-1.2260.085-0.007-0.0050.0030.1070.107-0.011-0.058-0.005
WPA (Winst Per Aandeel) 2.92.432.592.982.852.472.582.294.721.781.271.981.51.520.7710.18-3.471.97-0.04-0.0300.390000
Verwaterde WPA 2.882.422.582.972.842.462.582.294.711.781.271.961.491.510.7710.18-3.471.97-0.04-0.0300.390000
EBITDA 4,913.83,874.13,815.34,318.84,328.33,7873,805.63,5863,447.42,958.72,364.72,944.42,703.62,701.52,323.11,996.51,273.4-51.42,610.4323.3313.1628.425432.975430.6506.05146.05548.775
EBITDA ratio 0.2880.2510.2680.3240.3180.2950.3120.3140.3030.2770.2660.3020.2650.270.2980.2510.196-0.020.2480.1210.1120.0870.220.2190.0760.0230.082